<DOC>
	<DOC>NCT00399178</DOC>
	<brief_summary>To evaluate the efficacy and safety of Norspan versus Tiperol Retard among OA patients who are sub-optimally treated with current analgesic. Those patients may benefit from treatment with a long lasting analgesic.</brief_summary>
	<brief_title>A Randomised Open Controlled Parallel Group Study Comparing Norspan and Tramadol</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Tramadol</mesh_term>
	<criteria>OA diagnosis BS11 greater than or equal to 4 at base line Not adequately pain relieved with 4,000 mg paracetamol daily Treated with high potent opioids for their OA pain Treated with a regular dose for greater than one week of Tramadol, Codeine or dextropropoxifene during the last three months Other chronic conditions requiring frequent analgesic therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2006</verification_date>
	<keyword>Osteoarthritis</keyword>
	<keyword>Norspan versus Tramadol</keyword>
	<keyword>Randomised</keyword>
	<keyword>Efficacy and safety</keyword>
	<keyword>OA pain of the hip and/or knee</keyword>
</DOC>